The Greater Cannabis Co., Inc. engages in the business of cannabis related investment and development opportunities through online retail store, direct equity investments, joint ventures, licensing agreements, or acquisitions. The company is headquartered in Baltimore, Maryland and currently employs 1 full-time employees. The company went IPO on 2018-07-09. The firm is involved in additional research and development of cannabinoid-based therapeutics that reduce disruptive symptoms in patients suffering from neuropsychiatric disorders. The firm also focuses on developing new formulations around cannabinoid therapeutics. Its wholly owned subsidiary is Biocanrx, Inc.
GCAN stock price ended at $0.16 on 星期三, after dropping 11.11%
On the latest trading day May 06, 2026, the stock price of GCAN fell by 11.11%, dropping from $0.16 to $0.16. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.16 and a high of $0.16. On the latest trading day, the trading volume for GCAN rose by 4.5K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 5.1K shares were traded, with a market value of approximately $150.4K.